What's in Grand Theravac Life Sciences (Nanjing) Co., Ltd.'s pipeline?

Grand Theravac Life Sciences (Nanjing) Co., Ltd. has 2 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Grand Theravac Life Sciences (Nanjing) Co., Ltd.'s portfolio?

Top competitors by shared drug class: AbbVie, Archigen Biotech Limited, AstraZeneca, BioLineRx, Ltd., Bright Minds Biosciences Pty Ltd.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/grand-theravac-life-sciences-nanjing-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Grand Theravac Life Sciences (Nanjing) Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Grand Theravac Life Sciences (Nanjing) Co., Ltd. pipeline: 0 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
TVAV-008	TVAV-008	phase 3	S1P1 receptor modulator	S1P1	Immunology

Therapeutic area mix

Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AbbVie · 1 shared drug class
Archigen Biotech Limited · 1 shared drug class
AstraZeneca · 1 shared drug class
BioLineRx, Ltd. · 1 shared drug class
Bright Minds Biosciences Pty Ltd · 1 shared drug class
Celtic Pharma Development Services · 1 shared drug class
Daewoong Pharmaceutical Co. LTD. · 1 shared drug class
Eric Stephen Winer, MD · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Grand Theravac Life Sciences (Nanjing) Co., Ltd.:

Cite this brief

Drug Landscape (2026). Grand Theravac Life Sciences (Nanjing) Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/grand-theravac-life-sciences-nanjing-co-ltd. Accessed 2026-05-17.